Exploring tissue-specific genes for safer drug targets in Alzheimer's disease
Common Fund Gene Utility Compendium: A Systems Biology Resource to Explore Tissue-Specific Functional Genes and Druggable Genomes
This study is looking at special genes in different parts of the body to find new ways to treat Alzheimer's disease while minimizing side effects, making it easier for researchers to discover effective medications.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10983541 on NIH RePORTER |
What this research studies
This research investigates the role of tissue-specific genes in Alzheimer's disease to identify potential drug targets. By focusing on genes that are uniquely expressed in specific tissues, the study aims to enhance drug discovery and reduce side effects associated with treatments. The researchers will utilize advanced systems biology techniques to analyze protein-protein interaction networks, determining which genes are most critical in disease development. This innovative approach shifts the focus from traditional gene expression levels to the functional importance of genes within their biological context.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients with non-Alzheimer's forms of dementia or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer and more effective treatments for Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in targeting tissue-specific genes for drug development, suggesting that this approach could yield significant advancements in treatment.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Li, Hu — Mayo Clinic Rochester
- Study coordinator: Li, Hu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.